GlaxoSmithKline to sell Horlicks malted drinks business in UK
20 July 2017
GlaxoSmithKline recalls nearly 600,000 asthma inhalers over delivery system defect
07 April 2017
Emma Walmsley named Glaxo's first woman CEO
20 September 2016
Apple, GlaxoSmithKline in diagnostic platform pact
19 July 2016
European regulators approve GSK’s Strivelis therapy for children with combined immunodeficiency
01 June 2016
GlaxoSmithKline’s majority-owned HIV business to buy drugs from US rival Bristol-Myers Squibb
18 December 2015
GSK to sell its multiple sclerosis treatment drug to Novartis for $1 bn
21 August 2015
China to receive cut-price supplies of GSK’s new HIV drug Tivicay
02 July 2015
CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi
06 June 2015
GSK, University of North Carolina in HIV cure venture
11 May 2015
Novartis-GSK business deal gets CCI nod
23 December 2014
GSK abandons sale of older drugs portfolio
05 December 2014
GlaxoSmithKline's $1.57-bn restructuring to hit US jobs
04 December 2014
Ebola virus gives birth to a new vaccine
28 November 2014
GSK China's private investigators sentenced for theft, trading private information
09 August 2014
GlaxoSmithKline to launch first-ever malaria vaccine
26 July 2014
China indicts two foreign investigators in Glaxo bribery scam
14 July 2014
British watchdog launches criminal probe into GSK over bribery
28 May 2014
GSK’s former China head charged with bribery
14 May 2014
Novartis AG, GSK in $23-bn assets swap deal
22 April 2014
GSK's statement on media reports on misconduct of employees
17 April 2014
After China, Iraq, Poland, GSK bribery probe now expands to Jordan, Lebanon
17 April 2014
After China and Iraq, GSK now faces bribery probe in Poland
14 April 2014
GSK launches probe into unethical conduct in Iraq
09 April 2014
GSK spends $1.05 bn to raise stake in Indian arm
11 March 2014
GlaxoSmithKline to stop paying doctors for product promotion
17 December 2013
Glaxo announces open offer to hike stake in Indian arm
16 December 2013
GSK sells thrombosis drugs to Aspen for $1.13 billion
01 October 2013
Japan's Suntory to pay $2.11 bn for GSK’s Lucozade, Ribena soft drink brands
10 September 2013
GSK in talks to sell Lucozade, Ribena soft drinks to Suntory
06 September 2013
India revokes patent of GSK’s breast cancer drug Tykerb
02 August 2013
GSK to pay $229 mn to eight US states to settle diabetes drug Avandia lawsuits
25 July 2013
China detains four senior GSK employees over bribery
15 July 2013
China accuses GSK of bribery, raising prices and tax fraud
11 July 2013
GSK signs next-generation cancer drugs development deal with Immunocore
09 July 2013
GSK probes whether employees bribed doctors in China to prescribe Botox
08 July 2013
China launches probe on GSK over price fixing
05 July 2013
Blackstone, Lion Capital team up to bid for GSK’s soft drink brands
01 July 2013
Aspen Pharma offers to buy GlaxoSmithKline’s thrombosis brands
18 June 2013
GlaxoSmithKline to buy Swiss biotech firm Okairos
29 May 2013
GlaxoSmithKline plans to sell Lucozade and Ribena soft drink brands
24 April 2013
GSK accused of paying off rivals to delay entry of generic drugs
19 April 2013
GSK Pharma net up at Rs138.5 cr; proposes 500 per cent dividend
19 February 2013
GSK among others mulling upto $4-bn bid for Brazilian drugmaker Ache Laboratorios
13 February 2013
GSK ups stake in Indian arm to 72.5% in a Rs4,800-cr stock deal
05 February 2013
GSK, MD Anderson Cancer Center to develop new cancer drugs
10 December 2012
GSK Consumer Healthcare share buyback opens on 17 January
05 December 2012
Glaxo makes open offer to hike stake in Indian arm
26 November 2012
GSK to sell Australian generic portfolio to Aspen Pharma
16 August 2012
Human Genome Sciences agrees to GSK's revised $3-bn offer
17 July 2012
GSK to close Human Genome Sciences acquisition with $2.8-bn revised offer: report
16 July 2012
GlaxoSmithKline to pay record $3 billion in US drug fraud case
03 July 2012
GSK to buy new eczema drug Toctino from Basilea Pharmaceutica for £146 mn
12 June 2012
GlaxoSmithKline extends $2.6 billion offer for Human Genome Sciences
09 June 2012
Human Genome adopts poison pill to thwart $2.6-bn hostile GSK bid
18 May 2012
GlaxoSmithKline goes hostile with its $2.59-bn bid for Human Genome Sciences
09 May 2012
Aspen to buy GSK’s international OTC brands
20 April 2012
GlaxoSmithKline’s $2.6-bn bid rejected by Human Genome Sciences
19 April 2012
GSK to sell most European OTC drugs to Omega Pharma
15 March 2012
GlaxoSmithKline end-quarter 2011 net rises over 18 per cent to Rs137 crore
16 February 2012
GSK repatriating funds daily from European operations
08 February 2012
GSK to sell some North American OTC drugs to Prestige Brands for $661 mn
21 December 2011
GSK to pay $3 bn to settle US investigations for promoting drugs for unapproved uses
03 November 2011
Patented drugs overpriced, admits Glaxo CEO Witty
28 September 2011
GSK to pay $40.75 mn to 37 US states to settle sub-standard manufacturing lawsuit
24 June 2011
GlaxoSmithKline loses appeal in Rs71.21-crore Drug Price Equalisation Account demand
13 April 2011
GlaxoSmithKline to take $3.4-bn legal charge for diabetes drug Avandia
18 January 2011
GlaxoSmithKline acquires rights to Parkinson’s drug from Impax
16 December 2010
Glaxo to buy China's specialist drugmaker MeiRui Pharma for $70 million
08 December 2010
GlaxoSmithKline plans to acquire China’s Nanjing MeiRui Pharma
02 December 2010
GSK plans to invest £500 million in new projects in UK
01 December 2010
GlaxoSmithKline expands research collaboration with Brazil's Fiocruz
13 November 2010
GlaxoSmithKline to pay $750 mn to settle US adulterated drugs lawsuit
27 October 2010
Regulators in EU, US "kill" Glaxo’s diabetes drug Avandia
24 September 2010
GSK sues Roche over Genentech's cancer drug patent infringement
23 September 2010
UK regulator moots withdrawing GSK’s Avandia drug from UK market
06 September 2010
GSK investigates Pandermix link to chronic sleep disorder
04 September 2010
Glaxo follows Sanofi-Aventis to biotech major Genzyme
26 July 2010
GlaxoSmithKline net sales up 9 per cent
26 July 2010
FDA wants GSK to add more health warnings on diabetese drug Avandia
15 July 2010
GlaxoSmithKline: truth is a bitter pill
14 July 2010
Hyderabad-based Aptuit Laurus's parent to acquire GSK's Verona research operations
02 July 2010
GlaxoSmithKline acquires Argentina’s Laboratorios Phoenix for $253 million
11 June 2010
GSK acquires 9.9-per cent stake in S Korea's top phrma firm, Dong-A
12 May 2010
GSK Q1 earnings surge on swine flue vaccine
29 April 2010
GSK, Isis Pharma in RNA therapeutics licencing pact
31 March 2010
GlaxoSmithKline on the prowl for acquisitions in India
09 March 2010
GlaxoSmithKline forced to remove zinc from denture cream products
22 February 2010
GSK Pharma posts Q4 PAT of Rs103.59 crore
16 February 2010
GlaxoSmithKline keeps jobs as 2009 profit jump 12 per cent to £8.73 billion
05 February 2010
GlaxoSmithKline inks up to $330 million drug deal with Apeiron Biologics
03 February 2010
GlaxoSmithKline may follow AstraZeneca in axing jobs: report
01 February 2010
GSK inching closer to deal with Dr Reddy's?
08 January 2010
DCGI asks GSK to withdraw promotional campaign
26 December 2009
GSK and Intercell to develop innovative needle-free patch-based vaccines
12 December 2009
GlaxoSmithkline suspends operations at Andhra unit
11 December 2009
Glaxo targets emerging markets for acquisitions, tie-ups
11 December 2009
GSK receives orders for 440 million doses of H1N1 vaccine
06 October 2009
Glaxo seeking stake in Dr Reddy’s: report
18 September 2009
GSK to test swine flu vaccine in India at selected sites
03 September 2009
Glenmark faces GSK patent challenge in US over malaria drug
18 August 2009
GlaxoSmithKline retains Mahindra Satyam for IT deal
10 July 2009
GSK signs drug pact with Chroma Therapeutics
24 June 2009
Glaxo ties up with Dr Reddy's for emerging markets
15 June 2009
GSK in new venture pact with Shenzhen Neptunus to make influenza vaccines in China
09 June 2009
GSK close to acquiring Stiefel Lab for $3 billion
20 April 2009
GSK, Pfizer to merge HIV businesses into a new company
17 April 2009
Glaxo, Sanofi in talks for Shanta Biotch takeover
30 March 2009
GSK eyes push into emerging markets through Asken buy
28 March 2009
J&J, GSK, Novartis eye world's top dermatologist Stiefel
21 March 2009
Wockhardt to launch ulcer drug Ranitidine in the US
26 February 2009
Glaxo buys UCB patents
24 January 2009
GlaxoSmithKline acquires Bristol-Myers Squibb Pakistan
22 December 2008
GSK to focus on modern retail trade
31 October 2008
Horlicks may make Indian kids ‘taller, stronger, sharper’, but not in the UK
24 October 2008
Glaxo acquires oral care product Biotene for $170 million
22 October 2008
Ranbaxy-GSK submits IND application for respiratory inflammation candidate
13 October 2008
Kids channel Nick to go blank on 27 September to promote ‘Let’s Just Play’ initiative
01 September 2008
GlaxoSmithKline teams up with South Africa's Aspen to market branded generics
23 July 2008
Exelixis and GlaxoSmithKline to conclude six-year discovery and development collaboration
28 June 2008
Glaxo to cut 350 R&D jobs in drug research revamp
11 June 2008
GlaxoSmithKline, Daiichi in hypertension drug deal in India
14 May 2008
GSK Pharma signs licensing agreement with Astellas of Japan
05 May 2008
GlaxoSmithKline acquires Sirtris Pharmaceuticals
24 April 2008
US FDA approves Ranbaxy's generic version of GlaxoSmithKline's Ceftin for US sales
06 February 2008
Women’s Horlicks from GSK Consumer
30 January 2008
Ranbaxy announces settlement of possible Imitrex litigation with Glaxosmithkline
21 January 2008
GSK to launch cancer drug Tykerb in India
10 November 2007
Ranbaxy, GSK to settle valacyclovir patent case in US
26 July 2007
GlaxoSmithKline pharmaceuticals divests fine
26 July 2007
Ranbaxy-GSK alliance to develop respiratory drug
02 April 2007
Ranbaxy-Glaxo extend pact
07 February 2007
Glaxo moves court against Ranbaxy''s generic drug
03 February 2007
Glaxo buys Genmab's leukemia drug for record $2.1 billion
19 December 2006
Dr Reddy's to get generic rights as Glaxo settles Imitrex patent row
10 October 2006
GSK withdraws patent plea for AIDS drug Combivir
21 August 2006
GlaxoSmithKline Q2 net falls 12 per cent
27 July 2006
Ranbaxy acquires GlaxoSmithKline subsidiary Mundogen in Spain
18 July 2006
Ranbaxy to acquire Glaxo's generic business in Italy
28 March 2006
Oxford, GSK to partner in cancer research at leading clinical centres In India
17 October 2005
GSK makes a ''horlicks'' out its media meet
17 June 2005
GSK India announces buyback
15 March 2005
On the clinical trial trail
11 March 2005
GlaxoSmithKline to locate first Indian vaccine plant at Nashik
23 February 2005
GlaxoSmithKline Q4-05 up at 61.4%
17 February 2005
GSK sells worli plot for Rs107.6 crores
24 April 2004
GlaxoSmithKline, Burroughs Wellcome boards approve merger
18 March 2004
Horlicks gets new flavours
10 July 2003
GlaxoSmithKline announces a dividend of Rs 7 per equity share
13 March 2003
GlaxoSmithKline declares second interim dividend of 37%
21 December 2002
Glaxo SmithKline defers merger with Burroughs Wellcome
09 December 2002
Ranbaxy refutes Glaxo’s charge of stealing
24 August 2002
Glaxo SmithKline to sue Novartis, Ranbaxy
23 August 2002
GlaxoSmithKline interim dividend at 33%
31 July 2002
GlaxoSmithkline to launch new products
12 March 2002
Pharma sector fared well in 2001
28 December 2001
Pharma companies in talks with MIDC
13 December 2001
Iodex goes to SmithKline Healthcare
26 November 2001
GlaxoSmithKline''s plans for Affymax runs aground
31 July 2001
GlaxoSmithKline to sell-off Affymax
21 March 2001
GlaxoSmithKline strikes licensing deal with Merck
16 February 2001
Glaxo Wellcome, SmithKline Beecham agree to merge
17 January 2000
Large market share
17 January 2000
Why the merger worked this time
17 January 2000
 search domain-b